Speaker Profile

Ryan Neely

Biography
Ryan is CEO and co-founder of Skribe Medical. Previously, he was a co-inventor of ultrasound-powered Neural Dust implants at UC Berkeley and subsequently worked to commercialize this technology for wireless neurostimulation at iota Biosciences (exit to Astellas Pharma). He was also the first employee at Known Medicine (exit to Pathos AI) building an AI-powered cancer drug discovery platform based on patient-derived 3D microtumors. Ryan was most recently VP of Science at Elemind Technologies, helping to launch closed-loop neurostimulation wearables to accelerate sleep. Ryan is an author on 12 peer-reviewed publications and 11 patents.

---

Talk
Wearable cardiotoxicity protection for cancer patients
Skribe is developing an AI-powered wearable patch that enables early detection of heart damage caused by cancer therapy. We can alert doctors in time to administer heart-saving medication all with a battery-free, bandaid-like patch powered by a novel form of wireless energy and data transfer that maximizes patient comfort.

AI for Real-Time Monitoring and Remote Care Showcase:
Skribe Medical
Skribe is building a wearable patch to detect cardiotoxicity during cancer therapy. By sending energy and data across the skin surface from a watch to a small, battery-free patch, we enable a form factor to maximize long-term comfort and compliance for patients.